⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZURA News
Zura Bio Limited Class A Ordinary Shares
Form 8-K
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates
businesswire.com
ZURA
Form 8-K
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress
businesswire.com
ZURA
Zura Bio to Participate in Upcoming Investor Conferences
businesswire.com
ZURA